New cancer treatment approach could help immune cells fight tumors longer
- Released
- 2026-11-02 17:22
UCLA researchers found that boosting p53 protein with navtemadlin helped T cells fight melanoma cancer cells longer, but dosing challenges remain.
Your picks build your own list. Add items to lists and rank them.
Theme
UCLA researchers found that boosting p53 protein with navtemadlin helped T cells fight melanoma cancer cells longer, but dosing challenges remain.